Stichting Hemato-oncologie Voor Volwassenen Nederland

This study tests a new drug called tislelizumab combined with chemotherapy for people whose Hodgkin lymphoma has returned or not responded to first treatment. The goal is to see if this approach works as well as the standard intensive chemo and stem cell transplant. About 75 adul…

This study tests a daily pill called zanubrutinib for people with cold agglutinin disease, a rare condition where the immune system mistakenly destroys red blood cells, especially in cold weather. The drug aims to stop the abnormal immune cells from attacking red blood cells, pot…

This study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent cancer from returning in people with high-risk diffuse large B-cell lymphoma. About 109 adults aged 18-75 who achieved complete remission after initial treatment will …